Royalty Pharma plc
Current role
RPRX
Biotechnology · Healthcare
CEO, Board Member
2025-04-07–present
Vlad Coric
Board Member
Royalty Pharma plc (RPRX)Equibles does not estimate personal net worth.
Get an email with a short summary when Royalty Pharma plc publishes a filing, an earnings call transcript or a press release.
Get RPRX alertsAbout Vlad Coric
Vlad Coric is recorded as Board Member at Royalty Pharma plc (RPRX) since April 7, 2025 and CEO at Royalty Pharma plc (RPRX). The newest filing on record that lists Vlad Coric as CEO at Royalty Pharma plc (RPRX) is dated April 10, 2026. Royalty Pharma plc reported in an 8-K filed April 10, 2025 that Vlad Coric was appointed member of the Board of Directors, effective April 7, 2025. Royalty Pharma plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Royalty Pharma plc includes Pablo Legorreta (CEO), Christopher Hite (Chairman), David Hodgson (Chairman) and 7 others.
“Effective April 7, 2025, Dr. Vlad Coric was appointed to serve as a new member of the Board of Directors (the "Board") of Royalty Pharma plc (the "Company").”
Affiliation history
-
Current
2025-04-07–present
-
Current
Start not stated–present
Last confirmed April 10, 2026
Company network
Leadership on record at Royalty Pharma plc
- Pablo Legorreta CEO
- Christopher Hite Chairman
- David Hodgson Chairman
- Gregory Norden CFO
- Terrance Coyne CFO
- Arthur McGivern General Counsel
- Arthur R. McGivern General Counsel
- Carole Ho Board Member
- Catherine Engelbert Board Member
- Dr. Vlad Coric Board Member